ALBA-TCP Airlifts 20,000 Doses of Sinopharm Vaccine to Dominica

This Wednesday, March 3, through an air bridge organized as a solidarity effort of the ALBA-TCP alliance, 20,000 doses of China’s Sinopharm COVID-19 vaccine were transported to Dominica. ALBA-TCP’s recently established air bridge will permit the island’s inhabitants to be immunized.

With the financial support of the Bank of ALBA-TCP, and thanks to the relations with the Venezuelan Consortium of Aeronautical Industries and Air Services (Conviasa), this humanitarian air bridge was established to transport 20,000 vaccines donated by China to Dominica, announced the Minister of Foreign Relations, Jorge Arreaza, in a post on Twitter.

RELATED CONTENT: Oxfam Director: Israel’s Vaccine Export Deal “Shameful” as Nearly 5 Million Palestinians Wait

In January, following a meeting of the ALBA-TCP Social Council, ALBA Bank President Raúl Li Causi announced the establishment of the airlift. This would serve for the safe transfer of drugs purchased through ALBA-TCP’s Humanitarian Fund.

“In different phases, we will provide the financial support that the Eastern Caribbean countries will need, above all; including Antigua and Barbuda, Dominica, Saint Vincent and the Grenadines, Grenada, and Saint Kitts and Nevis,” said Li Causi.

RELATED CONTENT: Venezuela Receives 500,000 Doses of China’s Sinopharm Vaccine

The Sinopharm vaccine
The Sinopharm vaccine is based on a genetically altered version of the SARS-CoV-2 virus to generate an immune response.

China approved the COVID-19 vaccine, developed by state pharmaceuticals Sinopharm and the Beijing Institute of Biological Products, on December 30, 2020. Clinical trials published in The Lancet medical journal concluded that this vaccine is safe and effective.

Phase III trials were conducted in Peru, Egypt, Jordan, the United Arab Emirates, Bahrain, and Argentina. In them, an efficiency of 79.3% was shown. In addition, the report indicated that participants who received two doses produced high levels of antibodies (99.5%) against the virus.

In the United States, the media is currently promoting the Johnson & Johnson vaccine due to the problems of production and distribution of the Pfizer and AstraZeneca options. According to the World Health Organization the Johnson & Johnson vaccine is only 66% effective, and but still considered a good rate.

 

Featured image: Venezuelan state airline Conviasa supports ALBA-TCP in the delivery of COVID-19 vaccines donated by China to member countries, on this occasion to the island of Dominica. Photo courtesy of Minister Jorge Arreaza (@jaarreaza)

(RedRadioVE) by Patricia Ferrer, with Orinoco Tribune content

Translation: Orinoco Tribune

OT/JRE/SL

 

Website | + posts